Medication Titration & Immunizations for People with Diabetes

Principles of Medication Adjustment and Titration

Titration is the ongoing process of adjusting dose, timing, or regimen based on monitoring data, symptoms, and changing circumstances — it does not stop once a starting dose is prescribed.

Basal Insulin Titration

• Adjust based on the fasting/pre-breakfast glucose trend, not a single reading.
• A common treat-to-target approach increases the basal dose by a small fixed increment — commonly 2 units, or roughly 10% — every 3 days if fasting glucose remains above target and there is no hypoglycemia.
• ★ Watch for over-basalization. Signs include a basal dose exceeding roughly 0.5 units/kg/day, a large bedtime-to-morning glucose drop, high glucose variability, or hypoglycemia occurring even though fasting glucose is not yet at goal. Over-basalization signals a need to add prandial (mealtime) coverage, a GLP-1 receptor agonist, or another agent — not to simply keep increasing the basal dose.

Prandial (Mealtime) Insulin Titration

• Adjust the insulin-to-carbohydrate ratio and correction (sensitivity) factor based on post-meal and pre-meal glucose patterns, not isolated readings.
• ★ Account for the insulin's duration of action when timing correction doses to avoid insulin stacking — giving a second correction dose before the first has finished working, which compounds hypoglycemia risk. This is a particular concern with rapid-acting insulin's 3-5 hour duration when corrections are given too close together.
• The correction factor (insulin sensitivity factor, ISF) estimates how much 1 unit of insulin lowers glucose, calculated from the total daily dose (TDD, all basal plus all bolus insulin): the 1800 rule (1800 ÷ TDD) is used for rapid-acting analogs, and the 1500 rule (1500 ÷ TDD) is used for regular insulin. For example, a person with a TDD of 60 units on rapid-acting insulin has an ISF of 1800 ÷ 60 = 30 mg/dL per unit — each unit is expected to lower glucose by about 30 mg/dL, a calculation used to build correction-dose instructions and to evaluate whether a reported correction dose was appropriate for the glucose value it targeted.

General Titration Principles

• Titrate one variable at a time when possible so the cause of a glucose change can be identified.
• Reassess after every dose change using a consistent monitoring window (for example, a 3-day fasting glucose pattern) rather than reacting to a single outlier value.
• Involve the person using the medication in every adjustment decision; self-titration protocols (such as basal insulin dose-adjustment algorithms) are well supported when paired with structured education and follow-up.
• Non-insulin agents also require titration — metformin and GLP-1 receptor agonist/dual agonist doses are increased gradually specifically to improve GI tolerability, not primarily for glycemic reasons.

★ Immunizations for People with Diabetes

Diabetes increases the risk of severe outcomes from several vaccine-preventable illnesses, so routine immunization is an explicit part of comprehensive diabetes care per ADA Standards of Care and CDC/ACIP guidance.

Hepatitis B deserves special attention on the exam: diabetes is one of the few chronic conditions with its own dedicated historical ACIP recommendation for hepatitis B vaccination, originally issued because of documented hepatitis B outbreaks linked to shared blood glucose monitoring equipment (fingerstick devices, lancets) in long-term care and assisted-monitoring settings. The 2022 ACIP update made hepatitis B vaccination universally recommended for all unvaccinated adults aged 19-59 regardless of risk factors, which now covers most adults with diabetes in that age range; the diabetes-specific Category B recommendation persists for people 60 and older who were not previously vaccinated, with the decision weighing factors such as the likelihood of needing assisted blood glucose monitoring.

Teaching Points for the Educator

• Explain to the person why a dose is changing — the specific glucose pattern driving the decision — not just what the new dose is; this builds problem-solving skill for future adjustments.
• Confirm technique (injection site rotation, pen priming, resuspension of cloudy insulins) before assuming a titration failure reflects a dose problem rather than a technique problem.
• Fold immunization status into the standard diabetes visit checklist alongside A1C, blood pressure, lipids, and foot/eye screening — vaccination is a routine, evidence-based component of diabetes self-management education, not a separate primary-care task.